dsdsa

product

Manufacturer for Sofosbuvir - Pharmaceutical Grade 209216-23-9 Entecavir Monohydrate For Treatment of Chronic Hepatitis B – Yibai

Short Description:


Product Detail

FAQ

Product Tags

Related Video

Feedback (2)

Our business puts emphasis over the administration, the introduction of talented staff, plus the construction of team building, attempting hard to boost the standard and liability consciousness of personnel customers. Our corporation successfully attained IS9001 Certification and European CE Certification of Docetaxel Trihydrate, Velpatasvir, Docetaxel Powder, Welcome your visiting and any your inquires,sincerely hope we can have chance to cooperate with you and we can build up long well business relationship with you.
Manufacturer for Sofosbuvir - Pharmaceutical Grade 209216-23-9 Entecavir Monohydrate For Treatment of Chronic Hepatitis B – Yibai Detail:

Product name Entecavir monohydrate
Synonyms 2-Amino-1,9-dihydro-9-[(1S,3R,4S)-4-hydroxy-3-(hydroxymethyl)-2-methylenecyclopentyl]-6H-purin-6-one monohydrate
CAS No. 209216-23-9
Appearance White to off-white powder
Molecular Formula C12H15N5O3.H2O
Molecular Weight 295.30
Usage Pharmaceutical Grade or Research purpose
Packing As per your request
Storage Preserve in tight,light-resistant containers in a cool place

 

Entecavir monohydrate Cas: 209216-23-9

Items

Standard

Results

Appearance White to off-white powder Complies
Optical rotation +24.0°—+28.0°(DMF:MeOH=1:1 c=1%) +27.0°
Identification A: By IR, To match with working standard Complies
B: By HPLC,retain time should match with working standard Complies
Water 5.8%—6.5% 6.1%
Isomer Single ≤0.1% 0.02%
Total ≤0.5% 0.02%
Related Substances Single impurity ≤0.1% 0.05%
Total impurities ≤0.3% 0.07%
Residue on ignition ≤0.1% 0.04%
Heavy metals £ 10ppm Complies
Residual  solvents Should be to match with the standard Complies
Assay ≥99.8% 99.9%
Conclusion:Complies to the in-house standards.

Company Information

√ Management layer’s full experience in factory and skilled technicians followers;
√ Quality is always our top consideration, Strict QC system;
√ 11 years experienced exporting sales team;
√ Independent R&D lab;
√ Two signed long term GMP workshops;
√ Rich resources of plenty idle factories for customized project;
√ High Efficiency working team with consistent path.
imgsafSDGSHDASFG

Product detail pictures:

Manufacturer for Sofosbuvir - Pharmaceutical Grade 209216-23-9  Entecavir Monohydrate For Treatment of Chronic Hepatitis B – Yibai detail pictures

Manufacturer for Sofosbuvir - Pharmaceutical Grade 209216-23-9  Entecavir Monohydrate For Treatment of Chronic Hepatitis B – Yibai detail pictures

Manufacturer for Sofosbuvir - Pharmaceutical Grade 209216-23-9  Entecavir Monohydrate For Treatment of Chronic Hepatitis B – Yibai detail pictures


Related Product Guide:

We thinks what customers think, the urgency of urgency to act during the interests of a purchaser position of theory, allowing for much better good quality, lower processing costs, prices are extra reasonable, won the new and old buyers the support and affirmation for Manufacturer for Sofosbuvir - Pharmaceutical Grade 209216-23-9 Entecavir Monohydrate For Treatment of Chronic Hepatitis B – Yibai , The product will supply to all over the world, such as: Tunisia, Amsterdam, Slovenia, In the increasingly competitive market, With sincere service high quality products and well-deserved reputation, we always offer customers support on products and techniques to achieve long-term cooperation. Living by quality, development by credit is our eternal pursuit, We firmly believe that after your visit we will become long-term partners.
  • This company can be well to meet our needs on product quantity and delivery time, so we always choose them when we have procurement requirements.
    5 Stars By Lilith from Oman - 2017.08.16 13:39
    We have been engaged in this industry for many years, we appreciate the work attitude and production capacity of the company, this is a reputable and professional manufacturer.
    5 Stars By Emma from Slovenia - 2017.09.26 12:12
    Write your message here and send it to us